Consistent with previous studies, it was found that various levels of GLI1 were expressed in the cell lines, indicating that the HH/GLI1 pathway plays a pivotal role in NSCLC cancer cell progression (Fig. 1A). The gene discussed is GLI1; the disease is non-small cell lung carcinoma.